| Bioactivity | ?PKC(85–92),Myristoylated is a cell permeable myristic acid conjugated PKC? peptide activator that enhances NO release in cultured human umbilical vein endothelial cells (HUVECs)[1]. |
| Target | PKC? |
| Name | ɛPKC(85–92),Myristoylated |
| CAS | 1072301-79-1 |
| Sequence | {Myr}‐His-Asp-Ala-Pro-Ile-Gly-Tyr-Asp |
| Shortening | {Myr}‐HDAPIGYD |
| Formula | C53H80N10O15 |
| Molar Mass | 1097.26 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Castro J, et al. The Effects of Novel Myristoylated PKC Epsilon Peptide Modulators on Real‐Time Nitric Oxide Release in Human Umbilical Vein Endothelial Cells. The FASEB Journal, 2020, 34(S1): 1-1. |
ɛPKC(85–92),Myristoylated
CAS: 1072301-79-1 F: C53H80N10O15 W: 1097.26
?PKC(85–92),Myristoylated is a cell permeable myristic acid conjugated PKC? peptide activator that enhances NO release
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.